These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6321004)

  • 1. Cimetidine versus ranitidine for refractory Zollinger-Ellison syndrome.
    de Gara CJ; Gledhill T; Hunt RH
    Can Med Assoc J; 1984 Mar; 130(5):550, 554. PubMed ID: 6321004
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ranitidine and cimetidine in Zollinger-Ellison syndrome].
    Ribera E; González-Atienza J
    Med Clin (Barc); 1983 Dec; 81(20):924-5. PubMed ID: 6319838
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cimetidine, ranitidine and somatostatin in the medical treatment of acute and chronic Zollinger-Ellison syndrome].
    Gordillo J; Varas MJ
    Rev Esp Enferm Apar Dig; 1987 Dec; 72(6):749-50. PubMed ID: 2894045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Danne O; Maria J
    Nouv Presse Med; 1977 Nov; 6(38):3544-5. PubMed ID: 23518
    [No Abstract]   [Full Text] [Related]  

  • 5. Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine.
    Habal FM; Soldin SJ; Greenberg GR
    Can Med Assoc J; 1983 Aug; 129(3):256-8. PubMed ID: 6305470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of metastatic Zollinger-Ellison syndrome with high-dose H2-receptor antagonists.
    Johnston SR; Wright PL
    Br J Clin Pract; 1990 Dec; 44(12):792-3. PubMed ID: 2102253
    [No Abstract]   [Full Text] [Related]  

  • 7. Cimetidine vs ranitidine.
    Montgomery H
    J Kans Med Soc; 1983 Dec; 84(12):605. PubMed ID: 6317776
    [No Abstract]   [Full Text] [Related]  

  • 8. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
    Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
    Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cimetidine or ranitidine?].
    Lamers CB
    Ned Tijdschr Geneeskd; 1986 Apr; 130(16):716-9. PubMed ID: 3012376
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of H2 antagonists in Zollinger-Ellison syndrome].
    Dammann HG; Walter TA; Müller P; Simon B
    Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
    [No Abstract]   [Full Text] [Related]  

  • 11. [Description of a case of Zollinger-Ellison syndrome].
    de la Pierre M; Aricò S; Capussotti L; Dellepiane M; Marucci M; Gandini G; Imarisio P
    Minerva Med; 1984 May; 75(19):1153-8. PubMed ID: 6328367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
    Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
    Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of the surgical and medical treatment of the Zollinger-Ellison syndrome.
    Howard TJ; Passaro E
    Surg Annu; 1990; 22():93-106. PubMed ID: 2408174
    [No Abstract]   [Full Text] [Related]  

  • 15. [H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
    Hotz J
    Fortschr Med; 1984 Feb; 102(8):203-4. PubMed ID: 6086477
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
    Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ranitidine].
    Acero D
    Med Clin (Barc); 1983 Jul; 81(4):171-7. PubMed ID: 6312209
    [No Abstract]   [Full Text] [Related]  

  • 18. Ranitidine and cimetidine in Zollinger-Ellison syndrome.
    Mignon M; Vallot T; Mayeur S; Bonfils S
    Br J Clin Pharmacol; 1980 Aug; 10(2):173-4. PubMed ID: 6107118
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranitidine or cimetidine.
    McCarthy DM
    Ann Intern Med; 1983 Oct; 99(4):551-3. PubMed ID: 6312863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainties in the management of the Zollinger-Ellison Syndrome.
    Malagelada JR
    Gastroenterology; 1983 Jan; 84(1):188-9. PubMed ID: 6128287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.